Publication

The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases

Journal Contribution - Journal Editorial

Optimal local treatment for nodal oligorecurrent prostate cancer is unknown. The randomized phase 2 PEACE V-STORM trial will explore the best treatment approach in this setting. Early results on the acute toxicity profile are projected to be published in quarter 3, 2021.

Journal: European Urology Focus

ISSN: 2405-4569

Issue: 2

Volume: 7

Pages: 241 - 244

Publication year:2021

WoS Id: 000635166100011
PubMed Id: 33386290
DOI: https://doi.org/10.1016/j.euf.2020.12.010
Institutional Repository URL: https://lirias.kuleuven.be/3368327

Accessibility:Open

See also: The multicenter, randomized, phase 2 PEACE V-STORM trial : defining the best salvage treatment for oligorecurrent nodal prostate cancer metastases
See also: The multicenter, randomized, phase 2 PEACE V-STORM trial

Publication

The Multicenter, Randomized, Phase 2 PEACE V-STORM Trial: Defining the Best Salvage Treatment for Oligorecurrent Nodal Prostate Cancer Metastases

Journal Contribution - Journal Editorial

Authors/publisher

Research units